Cwm LLC Purchases 406 Shares of Ceridian HCM Holding Inc. (NYSE:CDAY)

Cwm LLC increased its stake in shares of Ceridian HCM Holding Inc. (NYSE:CDAY – Get Rating) by 22.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,253 shares of the company’s stock after acquiring an additional 406 shares during the quarter. Cwm LLC’s holdings in Ceridian HCM were worth $126,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of CDAY. Capital International Investors bought a new position in Ceridian HCM during the first quarter worth $366,250,000. Renaissance Technologies LLC boosted its stake in Ceridian HCM by 377.0% during the first quarter. Renaissance Technologies LLC now owns 822,000 shares of the company’s stock worth $56,204,000 after acquiring an additional 649,656 shares in the last quarter. Natixis boosted its stake in Ceridian HCM by 4,343.7% during the second quarter. Natixis now owns 630,968 shares of the company’s stock worth $29,706,000 after acquiring an additional 616,769 shares in the last quarter. Woodline Partners LP acquired a new position in Ceridian HCM during the second quarter worth $26,334,000. Finally, Bank of Nova Scotia raised its holdings in Ceridian HCM by 1,603.7% during the second quarter. Bank of Nova Scotia now owns 291,405 shares of the company’s stock worth $13,720,000 after buying an additional 274,301 shares during the last quarter.

Ceridian HCM Stock Performance

NYSE CDAY opened at $67.62 on Tuesday. Ceridian HCM Holding Inc. has a 52-week low of $43.23 and a 52-week high of $85.23. The company has a 50-day simple moving average of $64.74 and a 200 day simple moving average of $60.79. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.07 and a current ratio of 1.07. The company has a market capitalization of $10.27 billion, a PE ratio of -132.59 and a beta of 1.45.

Ceridian HCM (NYSE:CDAY – Get Rating) last posted its quarterly earnings data on Wednesday, November 2nd. The company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.02. The business had revenue of $315.60 million during the quarter, compared to the consensus estimate of $305.37 million. Ceridian HCM had a negative net margin of 6.52% and a negative return on equity of 2.39%. On average, research analysts predict that Ceridian HCM Holding Inc. will post -0.05 EPS for the current year.

Insiders Place Their Bets

In other Ceridian HCM news, COO Christopher R. Armstrong sold 24,070 shares of the stock in a transaction dated Tuesday, October 25th. The shares were sold at an average price of $60.00, for a total transaction of $1,444,200.00. Following the completion of the transaction, the chief operating officer now owns 100,477 shares in the company, valued at $6,028,620. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO Leagh Erin Turner sold 6,500 shares of the firm’s stock in a transaction that occurred on Monday, January 9th. The shares were sold at an average price of $61.52, for a total value of $399,880.00. Following the completion of the transaction, the chief executive officer now directly owns 176,643 shares in the company, valued at $10,867,077.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Christopher R. Armstrong sold 24,070 shares of the firm’s stock in a transaction that occurred on Tuesday, October 25th. The shares were sold at an average price of $60.00, for a total transaction of $1,444,200.00. Following the completion of the transaction, the chief operating officer now owns 100,477 shares of the company’s stock, valued at $6,028,620. The disclosure for this sale can be found here. Insiders sold 37,070 shares of company stock worth $2,251,890 over the last quarter. 3.90% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several research firms have weighed in on CDAY. Cowen upped their price objective on shares of Ceridian HCM from $70.00 to $77.00 and gave the stock an “outperform” rating in a report on Monday, November 14th. Cowen upped their price objective on shares of Ceridian HCM from $70.00 to $77.00 and gave the stock an “outperform” rating in a report on Monday, November 14th. JPMorgan Chase & Co. lowered their price objective on shares of Ceridian HCM from $75.00 to $70.00 and set a “neutral” rating on the stock in a report on Thursday, November 3rd. Moffett Nathanson started coverage on shares of Ceridian HCM in a report on Monday, January 9th. They set a “market perform” rating and a $68.00 price objective on the stock. Finally, Citigroup lowered their target price on shares of Ceridian HCM from $73.00 to $68.00 in a report on Friday, October 21st. One research analyst has rated the stock with a sell rating, five have given a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $70.93.

Ceridian HCM Profile

(Get Rating)

Ceridian HCM Holding Inc, together with its subsidiaries, operates as a human capital management (HCM) software company in the United States, Canada, and internationally. It offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud HR and payroll solution for the small business market.